Literature DB >> 543890

[Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].

D Bente, G Glatthaar, G Ulrich, M Lewinsky.   

Abstract

A randomized, double blind, cross-over study was carried out on long-term gerontopsychiatric patients. The aim of the study was to compare the EEG effects of a four weeks' treatment with 10-methoxy-1,6-dimethyl-ergoline-8 beta-methanol-(5-bromonicotinate) (nicergoline, Sermion) with those of dihydroergotoxin-mesylate (DHETM) and a four weeks' placebo period. The results of the power spectrum analysis with a consecutive factor analysis of the spectral data show that nicergoline and DHETM have a vigilance stabilizing effect which is characterized by a decrease in the relative power of slow delta-theta frequencies and an increase in the alpha power. As opposed to DHETM, for which this effect could not be proved, nicergoline produces a significant increase in power of the fast alpha frequencies as well as of the beta 1, beta 2, and beta 3 band.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 543890

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

Review 1.  Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Authors:  M Fioravanti; L Flicker
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.

Authors:  B Saletu; E Paulus; L Linzmayer; P Anderer; H V Semlitsch; J Grünberger; L Wicke; A Neuhold; I Podreka
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.